Related Experiment Video
Updated: Aug 11, 2026
04:40
Venous Thrombosis Assay in a Mouse Model of Cancer
Published on: January 5, 2024
[Antineoplastic treatment and venous thrombosis]
Christophe Desauw1, Jacques Bonneterre
1Département de sénologie, Centre Oscar Lambret, 59020 Lille Cedex. desauw.christophe@ghicl.net
Bulletin Du Cancer
|March 7, 2006
Summary
Cancer patients face high thrombosis risk due to factors like surgery and hypercoagulability. Low-molecular-weight heparin (LMWH) is effective for treatment but prevention is limited to post-surgery cases.
Area of Science:
- Oncology
- Hematology
- Vascular Medicine
Context:
- Cancer patients exhibit elevated thrombosis risk due to multifactorial causes including surgery, immobilization, and central venous access.
- Cancer itself promotes a hypercoagulable state, increasing the likelihood of thrombophlebitis, which is linked to poor prognosis and metastasis.
- Therapeutic interventions, particularly surgery and certain medical treatments like VEGF inhibitors and thalidomide, significantly elevate thrombosis incidence, sometimes up to 40% in combination.
Purpose:
- To review the heightened risk of thrombosis in cancer patients.
- To discuss the impact of cancer and its treatments on coagulation.
- To outline current therapeutic and preventive strategies for thrombosis in this population.
Summary:
- Cancer patients are at high risk for thrombosis due to intrinsic disease factors and iatrogenic influences from treatments like surgery and anti-angiogenic therapies.
- Thrombophlebitis in cancer is associated with poor outcomes and metastasis.
- Current curative treatment involves low-molecular-weight heparin (LMWH) for 3-6 months, while preventive LMWH is only recommended short-term post-surgery.
Impact:
- Highlights the critical need for vigilance regarding thrombosis in oncology.
- Informs clinical practice on managing thrombosis risk and treatment in cancer patients.
- Underscores limitations in current preventive strategies, necessitating further research outside the immediate post-operative setting.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...